|
|
Cambridge Heart, Inc. - Comparative Business Analysis Snapshot
Business Description
Cambridge Heart, Inc.. The Company's principal activity is to conduct research and develop and market products for the non-invasive diagnosis of cardiac disease. Its products incorporate its proprietary technology for the measurement of Microvolt T-Wave Alternans to non-invasively measure Microvolt levels of T-Wave Alternans in order to predict the risk of SCD.The Company's Heartwave System is used to perform a Microvolt T-Wave Alternans Test, a non-invasive measurement of subtle beat-to-beat fluctuation in a patient's heartbeat. Its CH 2000 performs conventional cardiac stress tests using the T-wave Alternans technology. All the products are cleared by the Federal Drug Administration for sale in the United States and have received the CE mark for sale in Europe. The Company sells its products primarily to cardiology group practices, hospitals and research institutions. It sells products in the United States, Europe and Asia.
Competitor Analysis
This analysis compares Cambridge Heart, Inc. with three other companies in closely related industry sectors.
The full Comparative Business Report is available to Subscribers or may be purchased individually. The full report generally includes the following sections:
- Sales Analysis: Recent Sales, Sales Growth, Sales per Employee
- Recent Stock Performance
- Company Valuation Ratios: Price/Earnings, Price/Book Value
- Price/Sales and 52 Week Price change
- Dividend Analysis
- Profitability Analysis: Gross Profit Margin, EBITDA Margin
- Earnings Before Extraordinary Items
- Inventory Analysis
- Research and Development Expenses
- Financial Position: Long Term Debt/Equity, Days Accounts Receivable, Days Inventory
- R&D Expenses/Sales
Not the Report you are looking for? Click here for more browsing options.
|
|
|
|
|
